Relmada Therapeutics Balance Sheet (2012-2026) | RLMD

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	4.67M	11.45M	44.44M	44.93M	37.26M	42.52M	5.40M	28.89M	14.47M	6.70M	4.09M	1.34M	2.09M	1.48M	3.86M	1.15M	1.35M	1.38M	3.50M	9.78M
Receivables - Net (Quarter)							0.51M
Receivables - Other (Quarter)		1.61M		3.61M			0.51M
Receivables (Quarter)							1.02M
Finished Goods (Quarter)
Prepaid Assets (Quarter)	1.55M	2.72M	0.23M	5.06M	3.48M	2.95M	4.04M	3.09M	3.47M	2.83M	0.12M	0.75M	0.54M	0.61M	0.89M	0.14M	0.31M	0.97M	0.98M	1.38M
Current Assets (Quarter)	110.70M	90.89M	223.30M	225.78M	215.74M	187.11M	152.87M	135.53M	122.00M	109.10M	97.51M	84.37M	70.97M	55.70M	45.80M	27.66M	21.09M	14.85M	93.98M	235.34M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
Other Non-Current Assets (Quarter)	0.03M	0.03M	0.03M	0.03M	0.04M	0.02M	0.00M	0.03M	0.49M	0.49M	0.04M	0.04M	0.05M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M
Non-Current Assets (Quarter)	0.07M	0.05M	0.03M	0.03M	0.04M	0.02M	0.03M	0.03M	0.03M	0.05M	0.04M	0.04M	0.05M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M
Assets (Quarter)	110.77M	90.93M	223.33M	225.81M	215.77M	187.12M	152.91M	135.57M	122.04M	109.15M	97.55M	84.41M	71.03M	55.72M	45.82M	27.68M	21.12M	14.88M	94.00M	235.36M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	10.46M	12.71M	11.19M	10.67M	7.54M	10.43M	5.26M	4.42M	4.85M	2.86M	3.51M	5.19M	4.17M	2.35M	4.13M	1.27M	1.36M	1.45M	1.57M	5.73M
Notes Payables (Quarter)
Payables (Quarter)	10.46M	12.71M	11.19M	10.67M	7.54M	10.43M	5.26M	4.42M	4.85M	2.86M	3.51M	5.19M	4.17M	2.35M	4.13M	1.27M	1.36M	1.45M	1.57M	5.73M
Accumulated Expenses (Quarter)	0.08M	5.54M	3.87M		11.38M	10.35M	7.21M	5.68M	0.07M	5.57M	8.69M	7.17M	5.36M	0.97M	6.16M	3.97M	1.89M	0.53M	0.54M	0.59M
Other Accumulated Expenses (Quarter)											0.12M			0.08M	0.13M	0.07M	0.08M	0.08M	0.13M	0.08M
Short term Debt (Quarter)
Current Taxes (Quarter)
Total Current Liabilities (Quarter)	13.92M	18.25M	15.06M	15.41M	18.92M	20.78M	12.47M	10.10M	10.70M	8.42M	12.19M	12.36M	9.54M	8.09M	10.29M	5.23M	5.13M	5.19M	6.43M	12.89M
Non-Current Liabilities
Non-Current Debt (Quarter)
Non-Current Deffered Revenue (Quarter)
Other Non-Current Liabilities (Quarter)														0.01M	0.00M	0.80M	0.03M	0.22M	1.06M	3.74M
Total Non-Current Liabilities (Quarter)														8.09M	10.29M	4.44M	5.13M	5.19M	6.43M	12.89M
Total Liabilities (Quarter)	13.92M	18.25M	15.06M	15.41M	18.92M	20.78M	12.47M	10.10M	10.70M	8.42M	12.19M	12.36M	9.54M	8.10M	10.30M	5.24M	5.17M	5.41M	7.49M	16.63M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)	96.85M	72.69M	208.26M	210.40M	196.85M	166.34M	140.44M	125.47M	111.34M	100.73M	85.36M	72.05M	61.49M	47.63M	35.52M	22.44M	15.95M	9.47M	86.51M	218.73M
Shareholder's Equity (Quarter)	96.85M	72.69M	208.26M	210.40M	196.85M	166.34M	140.44M	125.47M	111.34M	100.73M	85.36M	72.05M	61.49M	47.63M	35.52M	22.44M	15.95M	9.47M	86.51M	218.73M
Liabilities and Shareholders Equity (Quarter)	110.77M	90.93M	223.33M	225.81M	215.77M	187.12M	152.91M	135.57M	122.04M	109.15M	97.55M	84.41M	71.03M	55.72M	45.82M	27.68M	21.12M	14.88M	94.00M	235.36M
Retained Earnings (Quarter)	-228.08M	-270.69M	-305.07M	-344.81M	-384.75M	-424.17M	-462.11M	-488.43M	-513.74M	-535.74M	-560.90M	-582.73M	-600.50M	-622.22M	-640.88M	-658.44M	-668.31M	-678.40M	-698.27M	-717.32M
Preferred Shares (Quarter)
Treasury Shares (Quarter)							3.03M				2.38M			1.66M	1.38M	0.87M	0.75M	0.75M	5.88M	8.01M
Shares Outstanding (Quarter)	17.47M	17.50M	27.74M	29.40M	30.02M	28.64M	30.10M	30.10M	30.10M	30.10M	30.10M	30.17M	30.17M	30.17M	30.17M	33.19M	33.19M	33.19M	73.33M	104.89M

Research Tools

Relmada Therapeutics Balance Sheet (2012-2026) | RLMD

Create an account

Sign In

Reset Password